Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for Audited Consolidated and Standalone financial results for quarter and financial year ended March 31, 2026

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+18.0%1-day move

₹960.00

prior close

₹993.30

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.3-0.3-0.1-0.0+18.0+9.6+13.1+15.4+15.9+20.2+4.7+33.3+54.1—

Up moveDown movePending

AI summary

Senores Pharmaceuticals Limited has published extracts of its audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026 in Financial Express (English and Gujarati editions) on May 15, 2026. The company informed both BSE and NSE about this publication pursuant to SEBI LODR Regulations 30 and 47. The filing also includes various related party transaction disclosures and shareholder meeting notices under the Companies Act, 2013.

Likely market impact

This is a routine regulatory compliance filing announcing the publication of annual and quarterly financial results. Shareholders should refer to the published extracts for actual financial performance figures for FY2026.